Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03YHF
|
||||
Former ID |
DNC010431
|
||||
Drug Name |
Propan-2-one O-4-butoxybenzylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H22N2O3
|
||||
Canonical SMILES |
CCCCOC1=CC=C(C=C1)CNC(=O)ON=C(C)C
|
||||
InChI |
1S/C15H22N2O3/c1-4-5-10-19-14-8-6-13(7-9-14)11-16-15(18)20-17-12(2)3/h6-9H,4-5,10-11H2,1-3H3,(H,16,18)
|
||||
InChIKey |
VRTSWQPAWLHCJK-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.